JUNS - Jupiter Neurosciences, Inc. Operating income before deduction of amortization
Jupiter Neurosciences Inc (JUNS) leverages the deep scientific expertise of its management in developing early-stage biopharmaceutical projects. The company is penetrating unique niches by creating therapies for neuroinflammation and rare brain pathologies. Dependence on external research centers is mitigated by strict internal controls. The company's aggregate EBITDA on this chart demonstrates cash flow dynamics, where the value of 0.00 reflects this status.
Jupiter Neurosciences Inc - analytical breakdowns and key metrics (JUNS)
- share price and consensus valuation forecast:
- market capitalization statistics:
- balance sheet equity data:
- company total debt and liquidity indicators:
All Debt to Shareholders' Equity Ratio Jupiter Neurosciences Inc|JUNS - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital jupiterneurosciences.com|JUNS - Company Debts|Debt to Book Value Ratio Jupiter Neurosciences|JUNS - Company Long-Term Debts|Short-Term Debt Jupiter Neurosciences|Quick Ratio jupiterneurosciences.com
- financial results and valuation multiples details:
JUNS - Company Net Income|Expected Net Income Jupiter Neurosciences Inc|JUNS - Price to Earnings Ratio|Projected Price to Earnings Ratio Jupiter Neurosciences, Inc.|JUNS - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio Jupiter Neurosciences|JUNS - Operating profit EBITDA|Net earnings per share for the last 12 months Jupiter Neurosciences|JUNS - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months jupiterneurosciences.com|JUNS - Earnings growth in current year|Expected net earnings per share growth next year Jupiter Neurosciences Inc
Analysis of all company metrics:Jupiter Neurosciences, Inc. - JUNS
Jupiter Neurosciences Inc (JUNS) automates drug synthesis using algorithms, although medical support costs for clinical trials significantly impact cash flows. This metric aggregates operating income excluding depreciation, taxes, and interest; therefore, cash operating profit allows for an assessment of the business's actual ability to act as a cash generator, eliminating the risk of purchasing an overvalued asset.
Who Jupiter Neurosciences Inc competes with
BIIB (Biogen Idec) - Profit before deduction of interest, taxes, depreciation and amortization|Neurocrine Biosciences - Operating profit EBITDA|Operating income before deduction of amortization regencellbioscience.com RGC|AXSM (Axsome Therapeutics, Inc.) - Operating profit before deduction of amortization|ACAD: Company profit before taxes, interest and amortization|XENE (Xenon Pharmaceuticals Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization Viking Therapeutics Corp VKTX|Profit before payment of interest, taxes and amortization Supernus Pharmaceuticals (SUPN)|CPRX (catalystpharma.com) - Income before deduction of interest, taxes and amortization|Denali Therapeutics Inc. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization HRMY|BHVN - Profit before payment of interest, taxes and amortization|AMLX (Amylyx Corp) - Operating profit before amortization|TRVI: Operating profit EBITDA|Profit before interest, taxes and amortization praxismedicines.com (PRAX)|Operating profit before deduction of amortization AVXL|Operating profit EBITDA CeriBell Inc|Profit before payment of interest, taxes and amortization Prothena Corp (PRTA)|ALEC (alector.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Annexon, Inc. ANNX|Omeros Corp (OMER) - Profit before interest, taxes and amortization|NGNE - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization AC Immune S.A. ACIU|VYGR: Operating profit EBITDA|Operating profit before deduction of amortization Neumora Corp|SCLX (Scilex Holding Company) - Operating profit EBITDA|tevogen.com (TVGN) - Operating income before deduction of amortization|Operating profit EBITDA ACOG|CGTX - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Inhibikase IKT|SAVA: Operating profit before amortization|Assertio Therapeutics - Operating profit EBITDA|Coya Therapeutics, Inc. (COYA) - Operating profit before deduction of amortization|VTGN: Operating profit EBITDA|Profit before interest, taxes and amortization Ovid Therapeutics (OVID)|Profit before payment of interest, taxes and amortization Acumen Pharma|CervoMed Corporation (CRVO) - Operating income before deduction of amortization|Operating profit before deduction of amortization ATHE (Alterity Therapeutics)|CLNN (clene.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA PEPG (PepGen)|Operating income before deduction of amortization Relmada Therapeutics Inc (RLMD)|ANVS - Profit before payment of interest, taxes and amortization|GRCE (Grace Therapeutics, Inc.) - Operating profit before amortization|AIFF: Operating profit EBITDA|Operating profit before deduction of amortization Klotho Neurosciences|Profit before payment of interest, taxes and amortization NeuroSense Therapeutics Ltd|RVPH (Reviva Pharmaceuticals Holdings Inc.) - Company profit before taxes, interest and amortization|Operating profit before deduction of amortization MTVA (MetaVia Inc)|Operating profit EBITDA NeurAxis Inc (NRXS)|Profit before payment of interest, taxes and amortization Helius Medical Technologies HSDT|PASG: Operating profit before amortization|NEUP - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization Minerva Neurosciences Inc NERV|Athira (ATHA) - Profit before payment of interest, taxes and amortization|Operating profit before amortization ADXN|ALZN (Alzamend Neuro Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization Cyclerion CYCN|Operating profit before deduction of amortization PTIX (Protagenic Therapeutics)|Operating profit EBITDA pasitheaclinics.com (KTTA)|Profit before payment of interest, taxes and amortization Cortigent CRGT|Income before deduction of interest, taxes and amortization ATXI|BCLI - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization caratherapeutics.com|Chromocell Therapeutics Corp. (CHRO) - Profit before payment of interest, taxes and amortization|ELYM: Company profit before taxes, interest and amortization|Operating profit before deduction of amortization ITCI|Operating profit EBITDA Longboard|Profit before payment of interest, taxes and amortization Marinus Pharmaceuticals (MRNS)|NKGN: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA NRBO (NeuroBo Pharmaceuticals, Inc.)|Operating income before deduction of amortization Sage Therapeutics Inc. (SAGE)|SNPX: Operating profit before deduction of amortization|Trevena Inc - Company profit before taxes, interest and amortization|VIGL: Operating profit EBITDA|Profit before interest, taxes and amortization anewmeds.com (WENA)|Profit before payment of interest, taxes and amortization Cerevel Therapeutics, Inc.
